Skip to Main Content

Paper Details

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.
Adv Radiat Oncol
4
2022
Author NameAffiliation
Albert J ChangUniversity of California los angeles
Felix Y FengUniversity of California san francisco
Felix Y FengUniversity of California san francisco
  • 1 - 3

Datasets

Release 1.2